KeyBanc Capital Markets將Codex DNA的目標價從8美元調整為5美元,維持增持評級
MT Newswires2022/11/09 09:43 (美東)
Codex DNA分析師評級
Benzinga Analyst Ratings2022/11/09 04:51 (美東)
KeyBanc維持增持Codex DNA,將目標價下調至5美元
Benzinga Real-time News2022/11/09 04:51 (美東)
暫無數據